Document Type

Article

Publication Date

1-6-2018

Identifier

PMCID: PMC5753303; DOI: 10.2215/CJN.02110217

Abstract

BACKGROUND AND OBJECTIVES: High plasma concentration of fibroblast growth factor 23 (FGF23) is a risk factor for left ventricular hypertrophy (LVH) in adults with CKD, and induces myocardial hypertrophy in experimental CKD. We hypothesized that high FGF23 levels associate with a higher prevalence of LVH in children with CKD.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed echocardiograms and measured plasma C-terminal FGF23 concentrations in 587 children with mild-to-moderate CKD enrolled in the Chronic Kidney Disease in Children (CKiD) study. We used linear and logistic regression to analyze the association of plasma FGF23 with left ventricular mass index (LVMI) and LVH (LVMI ≥95th percentile), adjusted for demographics, body mass index, eGFR, and CKD-specific factors. We also examined the relationship between FGF23 and LVH by eGFR level.

RESULTS: Median age was 12 years (interquartile range, 8-15) and eGFR was 50 ml/min per 1.73 m

CONCLUSIONS: Plasma FGF23 concentration ≥170 RU/ml is an independent predictor of LVH in children with eGFR≥45 ml/min per 1.73 m

Journal Title

Clin J Am Soc Nephrol

Volume

13

Issue

1

First Page

45

Last Page

52

MeSH Keywords

Renal Insufficiency, Chronic; Hypertrophy, Left Ventricular; Child

Keywords

Body Mass Index; Confidence Intervals; EGFR protein, human; FGF23; Fibroblast Growth Factors; Hypertrophy, Left Ventricular; Logistic Models; Odds Ratio; Prevalence; Receptor, Epidermal Growth Factor; Renal Insufficiency, Chronic; adult; cardiovascular disease; child; children; chronic kidney disease; echocardiography; fibroblast growth factor 23; humans; left ventricular hypertrophy; risk factors

Share

COinS